GenScript Biotech Expands with New Operations and Logistics Center in Sydney, Enhancing Support for Australian Biotech

GenScript Biotech Corporation ("GenScript"), a global leader in life sciences services and products, has announced the establishment of new operations site...

November 11, 2024 | Monday | News
Trump’s Back – And Pharma’s Price Tags Might Be in for a Reality Check

  With a renewed focus on drug prices, fast-track approvals, and ‘America First’ production, industry experts warn pharma to brace for Tr...

November 07, 2024 | Thursday | Influencers
AstraZeneca to Create Over 800 Skilled Jobs in Asia with $1.5B ADC Manufacturing Facility in Singapore

AstraZeneca plans to hire over 800 employees in Singapore for highly skilled roles ranging from engineering, quality, technical services to global supply c...

November 07, 2024 | Thursday | News
GHIT Fund Commits JPY 578 Million to Pioneering Projects Targeting Malaria and Neglected Tropical Diseases

The Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately JPY 578 million (USD 4.0 million1) in four...

November 07, 2024 | Thursday | News
Lars Fruergaard Jørgensen Announces 21% Surge in Novo Nordisk’s Operating Profit, Driven by Strong Demand for Diabetes and Obesity Treatments

 Financial report for the period 1 January 2024 to 30 September 2024                      &nb...

November 06, 2024 | Wednesday | Company results
OmniActive Health Technologies Acquires ENovate Biolife to Expand Portfolio of Clinically Proven Health Ingredients

OmniActive Health Technologies (OmniActive) announced the acquisition of ENovate Biolife (ENovate), further strengthening its commitment to innovative...

November 05, 2024 | Tuesday | News
Illumina CEO Jacob Thaysen Announces Strong Q3 2024 Performance, Highlighting Strategic Wins Amid Industry Challenges

Illumina, Inc.  shared its financial results for the third quarter of fiscal year 2024, demonstrating resilience amidst macroeconomic challenges and...

November 05, 2024 | Tuesday | Company results
QIAGEN’s QIAstat-Dx Meningitis/Encephalitis Panel Cleared by FDA for Clinical Use

QIAstat-Dx Meningitis/Encephalitis Panel cleared in the U.S. for use in clinical settings to help diagnose central nervous system infections // Fourth ...

November 04, 2024 | Monday | News
Novo Nordisk's SELECT Trial Reveals Semaglutide 2.4 mg Reduces Hospital Admissions for Patients with Obesity and Cardiovascular Disease

Novo Nordisk presented an exploratory post hoc analysis from the SELECT phase 3 cardiovascular outcomes trial that showed semaglutide 2.4 mg significantly ...

November 04, 2024 | Monday | News
CEO Robert Spignesi Leads Rapid Micro Biosystems to Record Q3 Revenue Growth, Achieving 24% Year-Over-Year Increase

Reports record third quarter 2024 revenue of $7.6 million, representing growth of 24%compared to the third quarter of 2023 Placed seven Growth Direct&...

November 04, 2024 | Monday | Company results
American Lung Association Launches Free Lung Cancer Screenings for Illinois Residents in Honor of Lung Cancer Awareness Month

November is Lung Cancer Awareness Month, and the American Lung Association (Lung Association) is kicking it off by offering free lung cancer screenings to&...

November 01, 2024 | Friday | News
Bayer Debuts Industry-First PET Blister Packaging for Aleve, Pioneering Sustainable Change in Healthcare Packaging

Bayer has launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Reali...

October 31, 2024 | Thursday | News
Norman Schwartz Announces Bio-Rad’s Q3 Sales of $649.7 Million with 3.4% Currency-Neutral Growth, Driven by Clinical Diagnostics

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products,  announced financial r...

October 31, 2024 | Thursday | Company results
Abzena Expands Quality Control Testing Capabilities at San Diego Facility, Elevating Biologics Manufacturing and Microbiology Standards

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates announced a significant expansion in their quality control (QC) test...

October 31, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close